Better Coronavirus Stock: Johnson & Johnson vs. Novavax

Two very different drug companies recently joined the elite group of late-stage coronavirus vaccine companies. Johnson & Johnson (NYSE: JNJ) initiated a Phase 3 global clinical trial of JNJ-78436735 (also known as Ad26.COV2.S) on September 23. Novavax (NASDAQ: NVAX) started Phase 3 testing of its COVID-19 vaccine candidate in the UK the following day.

You should check here to buy the best price guaranteed products.

Last News

1998 Oregon school shooter: 'tremendous shame and guilt'

5 states pose a barrier to Biden's vaccine goals because they've so far vaccinated less than half of their population

US Pres Biden meets French Pres Macron at G7

In paying tribute to Pulse victims in Orlando, Biden shows the content of his character. So does DeSantis | Editorial

2 brides shopped separately for their wedding dresses and ended up choosing styles that were the perfect match

The Hilarious Moment Queen Elizabeth Insists on Using Sword to Cut Cake: 'This Is More Unusual'